|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2009-6-16
|
|
pubmed:abstractText |
liver disease resulting from chronic hepatitis C virus (HCV) infection follows an asymptomatic course towards cirrhosis and its complications in 20-40% of cases. Earlier studies demonstrated that advanced fibrosis is a prognostic factor. The "gold standard" for the evaluation of fibrosis grade is liver biopsy. Our group validated a predictive index - NIHCED - based on demographic, laboratory parameters, and echographic data to determine the presence of cirrhosis.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
1130-0108
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
101
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
325-35
|
|
pubmed:meshHeading |
pubmed-meshheading:19527078-Adult,
pubmed-meshheading:19527078-Aged,
pubmed-meshheading:19527078-Area Under Curve,
pubmed-meshheading:19527078-Biopsy,
pubmed-meshheading:19527078-Cohort Studies,
pubmed-meshheading:19527078-Early Diagnosis,
pubmed-meshheading:19527078-Female,
pubmed-meshheading:19527078-Hepatitis C, Chronic,
pubmed-meshheading:19527078-Humans,
pubmed-meshheading:19527078-Liver,
pubmed-meshheading:19527078-Liver Cirrhosis,
pubmed-meshheading:19527078-Liver Function Tests,
pubmed-meshheading:19527078-Male,
pubmed-meshheading:19527078-Middle Aged,
pubmed-meshheading:19527078-Platelet Count,
pubmed-meshheading:19527078-Predictive Value of Tests,
pubmed-meshheading:19527078-Prognosis,
pubmed-meshheading:19527078-Prospective Studies,
pubmed-meshheading:19527078-Sensitivity and Specificity,
pubmed-meshheading:19527078-Severity of Illness Index
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Prospective evaluation of liver fibrosis in chronic viral hepatitis C infection using the Sabadell NIHCED (Non-Invasive Hepatitis-C-Related Cirrhosis Early Detection) index.
|
|
pubmed:affiliation |
Service of Digestive Diseases, Universitat Autonoma de Barcelona, Barcelona, Spain. gbejarano@tauli.cat
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|
